Ocugen Insider Options Surge: CFO Confidence Signals Strategic Breakthroughs & Future Upside
Ocugen insider buying signals optimism for gene‑therapy milestones: CFO’s stake consolidation, zero‑cost options and a robust pipeline suggest a path to profitability despite current losses.
3 minutes to read